These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 13387963)

  • 21. Carbohydrate metabolism in brain diseases. X. Lack of effect of chlorpormazine and reserpine on abnormal carbohydrate metabolism in chronic schizophrenia.
    ALTSCHULE MD; GONCZ RM; HOLLIDAY PD
    AMA Arch Intern Med; 1957 Jun; 99(6):892-5. PubMed ID: 13423919
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognosis of schizophrenia before and after pharmacotherapy: II. Three-year follow-up.
    Pritchard M
    Br J Psychiatry; 1967 Dec; 113(505):1353-9. PubMed ID: 6078489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current status of the treatment of schizophrenia with chlorpromazine and reserpine].
    COULLAUT MENDIGUTIA R; COLINA LEONES MJ
    Rev Clin Esp; 1956 Dec; 63(5):315-29. PubMed ID: 13420828
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of chlorpromazine and reserpine therapy with follow-up study.
    STERNBERG U; SPITZ H; GOYNE JB
    J Clin Exp Psychopathol; 1957; 18(3):258-68. PubMed ID: 13463078
    [No Abstract]   [Full Text] [Related]  

  • 25. [Psychosomatic action of chlorpromazine and reserpine].
    HEPNER L; REVERCHON J; SAPIR M; SELZER S; STROUN J
    Encephale; 1956; 45(4):488-93. PubMed ID: 13384251
    [No Abstract]   [Full Text] [Related]  

  • 26. [Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
    HAASE HJ
    Nervenarzt; 1955 Dec; 26(12):507-10. PubMed ID: 13297074
    [No Abstract]   [Full Text] [Related]  

  • 27. Reserpine and chlorpromazine in hyperactive mental defectives.
    HORENSTEIN S
    Am J Ment Defic; 1957 Jan; 61(3):525-9. PubMed ID: 13381764
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of psychiatric disorders by chlorpromazine and reserpine; comparative study of various modes of administration of these drugs].
    JURQUET A; RANCE AM; ROGER J
    Encephale; 1956; 45(4):477-87. PubMed ID: 13384250
    [No Abstract]   [Full Text] [Related]  

  • 29. Chlorpromazine and reserpine; limitations of their use in office practice.
    GRIMSHAW JA
    J Kans Med Soc; 1956 Nov; 57(11):687-9. PubMed ID: 13367557
    [No Abstract]   [Full Text] [Related]  

  • 30. [Considerations on the association of chlorpromazine and reserpine in psychiatry].
    Plante N; Pelletier A; Langlois M
    Laval Med; 1958 Sep; 26(2):170-5. PubMed ID: 13589088
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action of chlorpromazine and reserpine on the anxiety of psychoneurotics].
    PELLERITO N
    Minerva Med; 1956 Sep; 47(73):628-31. PubMed ID: 13387158
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psychologic examination of patients treated by RP 4560 (chlorpromazine) and reserpine].
    ABRIC J; BOYER ; DUC N; LAFON R; POUGET R
    Encephale; 1956; 45(4):996-9. PubMed ID: 13384332
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effectiveness of psychotherapy of psychoses].
    Zakowska-Dabrowska T; Jankowska H
    Psychiatr Pol; 1979; 13(4):357-63. PubMed ID: 390580
    [No Abstract]   [Full Text] [Related]  

  • 34. [Echo of the symposium of Milan on reserpine and chlorpromazine in psychiatry].
    ZAMBIANCHI A
    Encephale; 1956; 45(4):1071-5. PubMed ID: 13384341
    [No Abstract]   [Full Text] [Related]  

  • 35. A critique of the tranquilizing drugs, chlorpromazine and reserpine, in neuropsychiatry.
    FREEMAN H
    N Engl J Med; 1956 Nov; 255(19):877-83. PubMed ID: 13369732
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlorpromazine and reserpine in the treatment of chronic mental illness.
    MORGAN DR
    Med J Aust; 1956 Jul; 43(2):57-62. PubMed ID: 13358339
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical remarks on valid indications of chlorpromazine and reserpine in infantile neuropsychiatry].
    Abric J; Faure JL
    Pediatrie; 1956; 11(7):773-6. PubMed ID: 13388536
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of chlorpromazine and reserpine on budgets of mental hospitals.
    TUTEUR W
    Am J Psychiatry; 1957 Jan; 113(7):657-9. PubMed ID: 13394737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advantages & disadvantages of extrapyramidal symptomatology in chlorpromazine & reserpine therapy].
    HAASE HJ
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1958; 197(4):367-76. PubMed ID: 13595869
    [No Abstract]   [Full Text] [Related]  

  • 40. [Psychomotility, extrapyramidal syndrome and mode of action of neuroleptic therapies; chlorpromazine, reserpine and prochlorperazine].
    FREYHAN FA
    Nervenarzt; 1957 Nov; 28(11):504-9. PubMed ID: 13517440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.